Archive · Business Recorder

Case-by-case review of pending drug-pricing cases ‘almost complete’

Pakistan Published 26 October 2026, 23:07 · archived 26 Oct 2026

The case-by-case evaluation of pending drug-pricing cases is nearing completion, with officials directed to move the cases forward for further processing, Business Recorder learnt on Monday. The development came as Federal Minister for Economic Affairs and Establishment Division Senator Ahad Cheema chaired a meeting on the Drug Regulatory Authority of Pakistan (DRAP) to review pending drug-pricing cases and the existing pricing formula. “Officials briefed the meeting that the case-by-case evaluation of pending drug-pricing cases is almost complete. Senator Ahad Cheema appreciated the progress ...

ZAZTEK archives the headline, summary and publication date so the story stays findable. The full article remains the publisher's. Read it at Business Recorder →